{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:09:21Z","timestamp":1792537761987,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG1N0111-3"],"award-info":[{"award-number":["CMRPG1N0111-3"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1053\/j.gastro.2025.11.005","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T20:22:28Z","timestamp":1763324548000},"page":"660-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perspectives on the Issues of Indeterminate\/Gray Zones of Chronic Hepatitis B Virus Infection"],"prefix":"10.1053","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-9372","authenticated-orcid":false,"given":"Yun-Fan","family":"Liaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.11.005_bib1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2025.11.005_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2025.11.005_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.11.005_bib4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.11.005_bib5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2024.11.018","article-title":"Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: a systematic review and meta-analysis","volume":"82","author":"Lai","year":"2025","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.11.005_bib6","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/liv.13416","article-title":"Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: benign course towards HBsAg clearance","volume":"37","author":"Oliveri","year":"2017","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2025.11.005_bib7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00535-022-01918-z","article-title":"Perspectives on current controversial issues in the management of chronic HBV infection","volume":"57","author":"Liaw","year":"2022","journal-title":"J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.11.005_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2023.04.009","article-title":"One ALT is not like the other","volume":"165","author":"Hunt","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.11.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840070102","article-title":"Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis","volume":"7","author":"Liaw","year":"1987","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.11.005_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2893.2011.01450.x","article-title":"Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion","volume":"19","author":"Chen","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2025.11.005_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cgh.2014.07.019","article-title":"Outcomes of patients with chronic hepatitis B who do not meet criteria for antiviral treatment at presentation","volume":"13","author":"Yapali","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.11.005_bib12","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/apt.14613","article-title":"Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the grey zone","volume":"47","author":"Bonacci","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.11.005_bib13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/jvh.13511","article-title":"Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone","volume":"28","author":"Yao","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2025.11.005_bib14","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/gutjnl-2025-335033","article-title":"Differential HCC risk among HBV indeterminate types at baseline and by phase transition","volume":"74","author":"Huang","year":"2025","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.11.005_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.21724","article-title":"Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase","volume":"46","author":"Hui","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.11.005_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cgh.2010.03.006","article-title":"Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase","volume":"8","author":"Chu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.11.005_bib17","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.14309\/ajg.0000000000000400","article-title":"Phase transition is infrequent among north American adults with e-antigen-negative chronic hepatitis B and low-level viremia","volume":"114","author":"Zhou","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.11.005_bib18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","article-title":"Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase","volume":"20","author":"Huang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.11.005_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2014.05.045","article-title":"Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection","volume":"61","author":"Spradling","year":"2014","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.11.005_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/HEP.0000000000001354","article-title":"Increased risk of HCC in HBeAg-negative indeterminate phase compared with HBeAg-negative chronic infection","volume":"83","author":"Hui","year":"2026","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.11.005_bib21","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.7326\/M24-0384","article-title":"Viral load-based prediction of hepatocellular carcinoma risk in noncirrhotic patients with chronic hepatitis B: a multinational study for the development and external validation of a new prognostic model","volume":"177","author":"Kim","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2025.11.005_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/gutjnl-2023-330225","article-title":"Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B","volume":"73","author":"Choi","year":"2024","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.11.005_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jceh.2021.12.011","article-title":"A prospective five-year follow-up after peg-interferon plus nucleotide analogue treatment or no treatment in HBeAg negative chronic hepatitis B patients","volume":"12","author":"Erken","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1053\/j.gastro.2025.11.005_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1473-3099(20)30692-7","article-title":"Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial","volume":"21","author":"Hsu","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1053\/j.gastro.2025.11.005_bib25","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/hep.31554","article-title":"Low incidence of adverse outcomes in adults with chronic hepatitis B virus infection in the era of antiviral therapy","volume":"73","author":"Lok","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.11.005_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41575-019-0197-8","article-title":"Clinical utility of HBV surface antigen quantitation in HBV e antigen-negative chronic HBV infection","volume":"16","author":"Liaw","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525064819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525064819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:37:54Z","timestamp":1775014674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508525064819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0016508525064819"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.11.005","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives on the Issues of Indeterminate\/Gray Zones of Chronic Hepatitis B Virus Infection","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the AGA Institute.","name":"copyright","label":"Copyright"}]}}